Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
A Phase 1/2 Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of Azacitidine in Combination With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors and Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Stage IV Microsatellite-Stable Colorectal Cancer (ECHO-206)
Sponsor: Incyte Corporation
Terminated
Study terminated by Sponsor
Other terminated trials from Incyte Corporation
- Healthy Participants · Phase PHASE1 · Oct 2025
- Advanced Solid Tumors · Phase PHASE1 · Sep 2025
- Advanced Solid Tumors · Phase PHASE1 · Jul 2025
- Metastatic Cholangiocarcinoma · Phase PHASE3 · Jul 2025
- Advanced Solid Tumors · Phase PHASE1/PHASE2 · Jun 2025
More terminations from Incyte Corporation
This PHASE1/PHASE2 trial investigates Advanced Malignancies and Metastatic Cancer and is currently terminated or withdrawn. Incyte Corporation leads this study, which shows 17 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
17 versions recorded-
Nov 2025 — Present [monthly]
Terminated PHASE1/PHASE2
-
Sep 2024 — Nov 2025 [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2021 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
Status: Completed → Terminated
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 12 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Nov 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2018 — May 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2018 — Apr 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2017 — Feb 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Incyte Corporation
For direct contact, visit the study record on ClinicalTrials.gov .